Tieu, Carolyn
Breder, Christopher D.
Funding for this research was provided by:
Oak Ridge Institute for Science and Education (RSR-702)
Article History
First Online: 16 August 2018
Compliance with Ethical Standards
:
: Carolyn Tieu has no conflicts of interest that are directly relevant to the content of this study. Christopher Breder is a medical officer at the US Food and Drug Administration (FDA); he is also the FDA Topic Expert in the M1 Points to Consider Group.
: Dr. Tieu’s fellowship was funded by an Oak Ridge Institute Science and Education Grant # RSR-702. The funding source had no role in the design and conduct of the study, analysis or interpretation of the data, and preparation or final approval of the manuscript prior to publication.
: The views expressed in this paper are the authors’ views and do not necessarily represent those of the FDA or the ICH.